|
|
|
|
|
|
|
|
|
4,7,13,16,21-Pentaoxa-1,10-diazabicyclo[8.8.5]tricosane [31364-42-8]
|
|
|
|
|
Identification |
|
Name |
|
4,7,13,16,21-Pentaoxa-1,10-diazabicyclo[8.8.5]tricosane |
|
Synonyms |
|
2,2,1-Cryptand; 2,2,1-Cryptate; Cryptand 2.2.1; Cryptand 221; Cryptate 221; Cryptofix 221; Kryptofix 221; NSC 321059 |
 |
|
Molecular Structure |
|
![CAS # 31364-42-8, 4,7,13,16,21-Pentaoxa-1,10-diazabicyclo[8.8.5]tricosane, 2,2,1-Cryptand, 2,2,1-Cryptate, Cryptand 2.2.1, Cryptand 221, Cryptate 221, Cryptofix 221, Kryptofix 221, NSC 321059](/structures/31364-42-8.gif) |
|
|
Molecular Formula |
|
C16H32N2O5 |
|
Molecular Weight |
|
332.44 |
|
CAS Registry Number |
|
31364-42-8 |
|
EINECS |
|
250-592-1 |
| |
|
Properties |
|
|
Solubility |
|
Very soluble (1000 g/L) (25 ºC), Calc.* |
|
Density |
|
1.11±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
| |
|
|
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2013 ACD/Labs)
|
|
| |
|
|
|
Safety Data |
|
|
MSDS |
|
Available |
| |
|
|
| Market Analysis Reports |
|
|
|
| |
|
|
|
|
|
